Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale

被引:5
|
作者
Tanislav, Christian [1 ]
Kaps, Manfred [1 ]
Jauss, Marek [1 ]
Stolz, Erwin [1 ]
Pabst, Wolfgang [2 ]
Nedelmann, Max [1 ]
Grebe, Mathias [3 ]
Reichenberger, Frank [4 ]
Allendoerfer, Jens [1 ]
机构
[1] Univ Giessen, Dept Neurol, Giessen, Germany
[2] Univ Giessen, Inst Biomed & Epidemiol, Giessen, Germany
[3] Univ Giessen, Dept Cardiol, Giessen, Germany
[4] Univ Giessen, Dept Pulmonol, Giessen, Germany
来源
BMC NEUROLOGY | 2010年 / 10卷
关键词
DEEP VENOUS THROMBOSIS; IMPENDING PARADOXICAL EMBOLISM; SILENT PULMONARY-EMBOLISM; TO-LEFT SHUNTS; TRANSCRANIAL DOPPLER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; RISK; EVENTS; THROMBOEMBOLISM; PREVALENCE;
D O I
10.1186/1471-2377-10-123
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In patients with patent foramen ovale (PFO) there is evidence supporting the hypothesis of a change in right-to-left shunt (RLS) over time. Proven, this could have implications for the care of patients with PFO and a history of stroke. The following study addressed this hypothesis in a cohort of patients with stroke and PFO. Methods: The RLS volume assessed during hospitalisation for stroke (index event/T0) was compared with the RLS volume on follow-up (T1) (median time between T0 and T1 was 10 months). In 102 patients with a history of stroke and PFO the RLS volume was re-assessed on follow-up using contrast-enhanced transcranial Doppler/duplex (ce-TCD) ultrasound. A change in RLS volume was defined as a difference of >= 20 microembolic signals (MES) or no evidence of RLS during ce-TCD ultrasound on follow-up. Results: There was evidence of a marked reduction in RLS volume in 31/102 patients; in 14/31 patients a PFO was no longer detectable. An index event classified as cryptogenic stroke (P < 0.001; OD = 39.2, 95% confidence interval 6.0 to 258.2) and the time interval to the follow-up visit (P = 0.03) were independently associated with a change in RLS volume over time. Conclusions: RLS volume across a PFO decreases over time, especially in patients with cryptogenic stroke. These may determine the development of new strategies for the management in the secondary stroke prevention.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
    Furlan, Anthony J.
    Reisman, Mark
    Massaro, Joseph
    Mauri, Laura
    Adams, Harold
    Albers, Gregory W.
    Felberg, Robert
    Herrmann, Howard
    Kar, Saibal
    Landzberg, Michael
    Raizner, Albert
    Wechsler, Lawrence
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) : 991 - 999
  • [32] Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke
    Thaler, David E.
    Ruthazer, Robin
    Weimar, Christian
    Serena, Joaquin
    Mattle, Heinrich P.
    Nedeltchev, Krassen
    Mono, Marie-Luise
    Di Angelantonio, Emanuele
    Elkind, Mitchell S. V.
    Di Tullio, Marco R.
    Homma, Shunichi
    Michel, Patrik
    Meier, Bernhard
    Furlan, Anthony J.
    Lutz, Jennifer S.
    Kent, David M.
    NEUROLOGY, 2014, 83 (21) : 1954 - 1957
  • [33] Prevention of stroke in patients with patent foramen ovale
    Mattle, H. P.
    Meier, B.
    Nedeltchev, K.
    INTERNATIONAL JOURNAL OF STROKE, 2010, 5 (02) : 92 - 102
  • [34] Diagnostic Yield of Pelvic Magnetic Resonance Venography in Patients With Cryptogenic Stroke and Patent Foramen Ovale
    Liberman, Ava L.
    Daruwalla, Vistasp J.
    Collins, Jeremy D.
    Maas, Matthew B.
    Botelho, Marcos Paulo Ferreira
    Ayache, Jad Bou
    Carr, James
    Ruff, Ilana
    Bernstein, Richard A.
    Alberts, Marc J.
    Prabhakaran, Shyam
    STROKE, 2014, 45 (08) : 2324 - 2329
  • [35] Patent Foramen Ovale and Cryptogenic Strokes in the Stroke in Young Fabry Patients Study
    Huber, Roman
    Grittner, Ulrike
    Weidemann, Frank
    Thijs, Vincent
    Tanislav, Christian
    Enzinger, Christian
    Fazekas, Franz
    Wolf, Markus
    Hennerici, Michael G.
    McCabe, Dominick J. H.
    Putaala, Jukaa
    Tatlisumak, Turgut
    Kessler, Christoph
    von Sarnowski, Bettina
    Martus, Peter
    Kolodny, Edwin
    Norrving, Bo
    Rolfs, Arndt
    STROKE, 2017, 48 (01) : 30 - +
  • [36] The Relationship Between the Triglyceride-Glucose Index and Cryptogenic Stroke in Patients with Patent Foramen Ovale
    Esin, Fatma
    Ince, Huseyin Sefa
    Akturk, Semih
    Citekci, Fahrettin Tugrul
    Celik, Aykan
    Kocabas, Ugur
    Kiris, Tuncay
    Karaca, Mustafa
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [37] Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
    Sondergaard, Lars
    Kasner, Scott E.
    Rhodes, John F.
    Andersen, Grethe
    Iversen, Helle K.
    Nielsen-Kudsk, Jens E.
    Settergren, Magnus
    Sjostrand, Christina
    Roine, Risto O.
    Hildick-Smith, David
    Spence, J. David
    Thomassen, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (11) : 1033 - 1042
  • [38] Assessment of the Characteristics of Patent Foramen Ovale Associated with Cryptogenic Stroke
    Pu H.
    Zhang Q.
    Wu J.
    Zhang Y.
    Zhao Y.
    Li L.
    Current Medical Imaging, 2024, 20
  • [39] Patent Foramen Ovale: Comparison among Diagnostic Strategies in Cryptogenic Stroke and Migraine
    Zito, Concetta
    Dattilo, Giuseppe
    Oreto, Giuseppe
    Di Bella, Gianluca
    Lamari, Annalisa
    Iudicello, Raffaella
    Trio, Olimpia
    Caracciolo, Giuseppe
    Coglitore, Sebastiano
    Arrigo, Francesco
    Carerj, Scipione
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2009, 26 (05): : 495 - 503
  • [40] Patent Foramen Ovale and Stroke
    Mono, M. -L.
    Nedeltchev, K.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (05) : 288 - 297